NM_019066.5:c.3151C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_019066.5(MAGEL2):​c.3151C>A​(p.Leu1051Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0239 in 1,613,880 control chromosomes in the GnomAD database, including 761 homozygotes. In-silico tool predicts a benign outcome for this variant. 9/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 135 hom., cov: 32)
Exomes 𝑓: 0.023 ( 626 hom. )

Consequence

MAGEL2
NM_019066.5 missense

Scores

1
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.122

Publications

7 publications found
Variant links:
Genes affected
MAGEL2 (HGNC:6814): (MAGE family member L2) Prader-Willi syndrome (PWS) is caused by the loss of expression of imprinted genes in chromosome 15q11-q13 region. Affected individuals exhibit neonatal hypotonia, developmental delay, and childhood-onset obesity. Necdin (NDN), a gene involved in the terminal differentiation of neurons, localizes to this region of the genome and has been implicated as one of the genes responsible for the etiology of PWS. This gene is structurally similar to NDN, is also localized to the PWS chromosomal region, and is paternally imprinted, suggesting a possible role for it in PWS. [provided by RefSeq, Oct 2010]
MAGEL2 Gene-Disease associations (from GenCC):
  • Schaaf-Yang syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0024078488).
BP6
Variant 15-23644592-G-T is Benign according to our data. Variant chr15-23644592-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 158812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-23644592-G-T is described in CliVar as Benign/Likely_benign. Clinvar id is 158812.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0577 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAGEL2NM_019066.5 linkc.3151C>A p.Leu1051Ile missense_variant Exon 1 of 1 ENST00000650528.1 NP_061939.3 Q9UJ55

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAGEL2ENST00000650528.1 linkc.3151C>A p.Leu1051Ile missense_variant Exon 1 of 1 NM_019066.5 ENSP00000497810.1 Q9UJ55

Frequencies

GnomAD3 genomes
AF:
0.0355
AC:
5399
AN:
152108
Hom.:
131
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0592
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.0479
Gnomad SAS
AF:
0.0413
Gnomad FIN
AF:
0.0599
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0207
Gnomad OTH
AF:
0.0411
GnomAD2 exomes
AF:
0.0312
AC:
7771
AN:
249212
AF XY:
0.0313
show subpopulations
Gnomad AFR exome
AF:
0.0610
Gnomad AMR exome
AF:
0.0126
Gnomad ASJ exome
AF:
0.0348
Gnomad EAS exome
AF:
0.0484
Gnomad FIN exome
AF:
0.0592
Gnomad NFE exome
AF:
0.0220
Gnomad OTH exome
AF:
0.0339
GnomAD4 exome
AF:
0.0227
AC:
33142
AN:
1461654
Hom.:
626
Cov.:
32
AF XY:
0.0235
AC XY:
17069
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.0681
AC:
2279
AN:
33480
American (AMR)
AF:
0.0136
AC:
609
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0331
AC:
865
AN:
26136
East Asian (EAS)
AF:
0.0425
AC:
1686
AN:
39700
South Asian (SAS)
AF:
0.0387
AC:
3341
AN:
86258
European-Finnish (FIN)
AF:
0.0600
AC:
3201
AN:
53364
Middle Eastern (MID)
AF:
0.0484
AC:
279
AN:
5768
European-Non Finnish (NFE)
AF:
0.0171
AC:
19054
AN:
1111852
Other (OTH)
AF:
0.0303
AC:
1828
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
2115
4229
6344
8458
10573
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0356
AC:
5421
AN:
152226
Hom.:
135
Cov.:
32
AF XY:
0.0374
AC XY:
2786
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0596
AC:
2475
AN:
41520
American (AMR)
AF:
0.0165
AC:
252
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0305
AC:
106
AN:
3470
East Asian (EAS)
AF:
0.0478
AC:
247
AN:
5170
South Asian (SAS)
AF:
0.0415
AC:
200
AN:
4818
European-Finnish (FIN)
AF:
0.0599
AC:
636
AN:
10614
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0206
AC:
1404
AN:
68016
Other (OTH)
AF:
0.0417
AC:
88
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
266
532
798
1064
1330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0262
Hom.:
184
Bravo
AF:
0.0328
TwinsUK
AF:
0.0189
AC:
70
ALSPAC
AF:
0.0171
AC:
66
ESP6500AA
AF:
0.0539
AC:
214
ESP6500EA
AF:
0.0212
AC:
177
ExAC
AF:
0.0323
AC:
3900
Asia WGS
AF:
0.0610
AC:
212
AN:
3478
EpiCase
AF:
0.0225
EpiControl
AF:
0.0216

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 18, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 08, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
6.7
DANN
Benign
0.82
DEOGEN2
Benign
0.035
T;T
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.068
.;T
MetaRNN
Benign
0.0024
T;T
PhyloP100
0.12
PrimateAI
Uncertain
0.60
T
Sift4G
Benign
1.0
T;.
Vest4
0.039
MPC
0.069
GERP RS
3.5
Varity_R
0.047
gMVP
0.14
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2233070; hg19: chr15-23889739; COSMIC: COSV58566715; API